Triple

T14008581
Position Surface form Disambiguated ID Type / Status
Subject Moderna E337017 entity
Predicate receivedAuthorizationFor P112134 FINISHED
Object COVID-19 vaccine E123479 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: COVID-19 vaccine | Statement: [Moderna, receivedAuthorizationFor, COVID-19 vaccine]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: COVID-19 vaccine
Context triple: [Moderna, receivedAuthorizationFor, COVID-19 vaccine]
  • A. COVID-19 vaccines chosen
    COVID-19 vaccines are immunizations developed to protect against the SARS-CoV-2 virus, significantly reducing the risk of severe illness, hospitalization, and death from COVID-19.
  • B. Vaxzevria COVID-19 vaccine
    Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
  • C. Sputnik V COVID-19 vaccine
    Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
  • D. Janssen COVID-19 Vaccine
    The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
  • E. mRNA vaccine
    An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: receivedAuthorizationFor
Context triple: [Moderna, receivedAuthorizationFor, COVID-19 vaccine]
  • A. receivedPromiseAbout
    Indicates that one entity has been given an assurance or commitment concerning another entity or event by some source.
  • B. receivedFor
    Indicates that something was obtained, accepted, or taken into possession on behalf of or for the benefit of a specified entity.
  • C. usedToAuthorize
    Indicates that something serves as the basis or instrument for granting permission, approval, or official power to perform an action.
  • D. reauthorizedBy
    Indicates that an existing authorization, approval, or mandate has been renewed or extended by a specific agent or authority.
  • E. reauthorizedIn
    Indicates that an existing authorization, agreement, or mandate was renewed or granted again at a specific time or in a specific context.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d81c645c5c8190b1fd16a285a1b78a completed April 9, 2026, 9:38 p.m.
NER Named-entity recognition batch_69de2ed44f90819099ad08c09c066b56 completed April 14, 2026, 12:11 p.m.
NED1 Entity disambiguation (via context triple) batch_69fbaca5fb48819090fff1fd22e8a15c completed May 6, 2026, 9:03 p.m.
PD Predicate disambiguation batch_69dd465dfbc4819090d8c61fd572d35f completed April 13, 2026, 7:39 p.m.
PDg Predicate description generation batch_69de01ed2098819088ec45069f6f2609 completed April 14, 2026, 8:59 a.m.
Created at: April 9, 2026, 10:19 p.m.